Introduction: High blood pressure (HBP) is a worldwide health issue responsible of high cardiovascular morbidity and mortality. Even though essential HBP is far the most frequently reported in patients, secondary causes must be known because of their severity and the possibility of aetiological treatment. No recent epidemiological data are available about secondary causes of HBP in black African populations. The aim of this study was to describe aetiological patterns of secondary HBP in patients followed at Saint-Louis Hospital. Patients and Method: We conducted a retrospective and descriptive study in regional hospital of Saint-Louis. All patients aged ≥15 years old admitted from January 1st 2011 to January 31st 2015 in internal medicine, nephrology, emergency and cardiology departments were included. Clinical, paraclinical data and patients outcomes were collected from medical records. Hypertension was defined according to JNC8 criteria. Secondary HBP was considered if explorations identified a clear aetiology to hypertension. Statistical analysis was done with Excel 2010 and STATA 12.0. Results: We included 9253 patients with mean age of 35 ± 12 years (15 - 83 years) and sex-ratio of 1.6. Overall 67.5% of patients had hypertension and secondary causes were found in 10.5% of them. The majority of patients presented clinical symptoms suggesting a secondary cause of HBP and first-line laboratory explorations were normal in half of cases. Renal diseases were responsible for 79.1% of secondary HBP cases mainly dominated by glomerulonephritis (22.6%), vascular nephropathies (18.7%) and autosomal dominant polycystic kidney disease (5.8%). They were followed by preeclampsia (13.6%) and endocrinal aetiologies such as hyperthyroidism (5.8%), hypercorticism (0.5%), pheochromcytoma (0.5%), primary hyperparathyroidism (0.4%) and Conn’s adenoma (0.1%). Combination of ≥3 antihypertensive drugs was necessary in 71.5% of cases and surgical treatment was performed in three patients. Blood pressure was normalized in only 27.7% of patients. Conclusion: Secondary causes are frequent in our young patients with HBP. In the majority of patients complete clinical examination and minimal laboratory investigations recommended by World Health Organisation can give an aetiological orientation that needs further radiological and hormonal explorations.
References
[1]
Thomas, D., Collet, J.P., Cottin, Y., et al. (2007) The Best of Epidemiology and Cardiovascular Prevention in 2006. Archives des Maladies du Coeur et des Vaisseaux, 100, 57-64.
[2]
Ong, K.L., Cheung, B.M.Y., Man, Y.B., et al. (2007) Prevalence, Awareness, Treatment, and Control of Hypertension among United States Adults 1999-2004. Hypertension, 49, 69-75. http://dx.doi.org/10.1161/01.HYP.0000252676.46043.18
[3]
Rudnick, K.V., Sackett, D.L., Hirst, S., et al. (1977) Hypertension in a Family Practice. Canadian Medical Association Journal, 117, 492-497.
[4]
Anderson Jr., G.H., Blakeman, N. and Streeten, D.H.P. (1994) The Effect of Age on Prevalence of Secondary Forms of Hypertension in 4429 Consecutively Referred Patients. Journal of Hypertension, 12, 609-615. http://dx.doi.org/10.1097/00004872-199405000-00015
[5]
Omura, M., Saito, J., Yamaguchi, K., Kakuta, Y. and Nishikawa, T. (2004) Prospective Study on the Prevalence of Secondary Hypertension among Hypertensive Patients Visiting a General Outpatient Clinic in Japan. Hypertension Research, 27, 193-202. http://dx.doi.org/10.1291/hypres.27.193
[6]
Akpunonu, B.E., Mulrow, P.J. and Hoffman, E.A. (1996) Secondary Hypertension: Evaluation and Treatment. Disease-a-Month, 42, 609-722. http://dx.doi.org/10.1016/S0011-5029(96)90019-X
[7]
Plouin, P.F., La Batide Alanore, A., Fiquet-Kempf, B., et al. (2002) Hypertension artérielle de cause curable chez l’adulte. La Presse Médicale, 31, 371-378.
[8]
Calhoun, D.A., Jones, D., Textor, S., et al. (2008) Resistant Hypertension: Diagnosis, Evaluation, and Treatment. A Scientific Statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension, 51, 1403-1419. http://dx.doi.org/10.1161/HYPERTENSIONAHA.108.189141
[9]
Nishizaka, M.K., Pratt-Ubunama, M., Zaman, M.A., Cofield, S. and Calhoun, D.A. (2005) Validity of Plasma Aldosterone-to-Renin Activity Ratio in African American and White Subjects with Resistant Hypertension. American Journal of Hypertension, 18, 805-812. http://dx.doi.org/10.1016/j.amjhyper.2005.01.002
[10]
Sinclair, A.M., Isles, C.G., Brown, I., et al. (1987) Secondary Hypertension in a Blood Pressure Clinic. Archives of Internal Medicine, 147, 1289-1293. http://dx.doi.org/10.1001/archinte.1987.00370070103015
[11]
Gordon, R.D., Stowasser, M., Tunny, T.J., et al. (1994) High Incidence of Primary Aldosteronism in 199 Patients Referred with Hypertension. Clinical and Experimental Pharmacology and Physiology, 21, 315-318. http://dx.doi.org/10.1111/j.1440-1681.1994.tb02519.x
[12]
Januszewicz, W., Chodakowska, J. and Styczynski, G. (1998) Secondary Hypertension in the Elderly. Journal of Human Hypertension, 12, 603-606. http://dx.doi.org/10.1038/sj.jhh.1000673
[13]
Saelen, M.G., Prøsch, L.K., Gudmundsdottir, H., et al. (2005) Controlling Systolic Blood Pressure Is Difficult in Patients with Diabetic Kidney Disease Exhibiting Moderate-to Severe Reductions in Renal Function. Blood Pressure, 14, 170-176. http://dx.doi.org/10.1080/08037050510008959